1. c-Met in chromophobe renal cell carcinoma
    Franziska Erlmeier et al, 2017, Medical Oncology CrossRef
  2. Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met
    Mohamed Y. Zaky et al, 2020, Archives of Biochemistry and Biophysics CrossRef
  3. Plasticity of Cancer Cell Invasion—Mechanisms and Implications for Therapy
    V. te Boekhorst et al, 2016, Molecular and Cellular Basis of Metastasis: Road to Therapy CrossRef
  4. Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation
    Ram Raj Prasad et al, 2022, Heliyon CrossRef
  5. The inhibitory effect of 5,7‐DMF on pancreatic sphere‐forming cell function mediated by FoxM1 gene expression
    Deyu Zeng et al, 2018, Journal of Cellular Biochemistry CrossRef
  6. Gradient Magnetic Separation and Fluorescent Imaging‐Based Heterogeneous Circulating Tumor Cell Subpopulations Assay with Biomimetic Multifunctional Nanoprobes
    Ziyi Liao et al, 2021, Advanced Functional Materials CrossRef
  7. Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
    Pengxiao Su et al, 2023, Frontiers in Oncology CrossRef
  8. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment
    Davide Frumento et al, 2024, International Journal of Molecular Sciences CrossRef
  9. Inhibition of c-MET reverses radiation-induced malignant potential in pancreatic cancer
    Soichiro Mori et al, 2021, Cancer Letters CrossRef
  10. CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR-495-MET-eIF4G1 translational regulation axis
    Yajie Zhao et al, 2022, Cell Death & Disease CrossRef
  11. MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
    Ai-Hua Chen et al, 2017, Cancer Cell International CrossRef
  12. Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c‑met
    Yan Shu et al, 2017, Oncology Letters CrossRef
  13. Calycosin down-regulates c-Met to suppress development of glioblastomas
    Xiaohu Nie et al, 2019, Journal of Biosciences CrossRef
  14. Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis
    Jifeng Peng et al, 2016, Disease Markers CrossRef
  15. Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B
    Ryshtee Mary Tannoo et al, 2024, Biochimica et Biophysica Acta (BBA) - Biomembranes CrossRef
  16. Nongenetic Approach for Imaging Protein Dimerization by Aptamer Recognition and Proximity-Induced DNA Assembly
    Hong Liang et al, 2018, Journal of the American Chemical Society CrossRef
  17. A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling
    W Li et al, 2017, Oncogene CrossRef
  18. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer
    Milind Pore et al, 2016, Clinical Lung Cancer CrossRef